After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

Donald Trump continues to make waves in biopharma; Sage rejects Biogen’s unsolicited takeover offer; the obesity space sees ...

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

If he’s confirmed as health secretary, Robert F. Kennedy Jr. will have broad authority to pursue an anti-vaccine agenda.

Novavax’s COVID-19 vaccine produced higher ... In this video from JPM 2025, pharmaphorum chats with SIFI CEO and Chairman Fabrizio Chines about a new treatment for acanthamoeba keratitis.

The most recent trading session ended with Novavax (NVAX) standing at $9.34, reflecting a +1.3% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily loss of 1.46%.

Webull, a popular online stock platform that has come under scrutiny by policymakers in Washington over its ties to China, has hired its first federal lobbyists.

Novavax (NVAX) closed at $9.34 in the latest trading session, marking a +1.3% move from the prior day. The average of price targets set by Wall Street analysts indicates a potential upside of 81.6 ...

A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...

XRP Ledger’s native decentralized exchange (DEX) has clocked $400 million in swap volume in January, averaging approximately $17 million per day, Ripple CEO Brad Garlinghouse said on Jan. 28.

UnitedHealth Group named Tim Noel as the new CEO of the UnitedHealthcare division Shutterstock Nearly two months after UnitedHealthcare CEO Brian Thompson was fatally shot in New York City in a ...